Shenwu Zhang

Shenwu Zhang

Auto-generated profile, based on publicly available information

Shenwu Zhang

Department of Pharmaceutics Wuya College of Innovation Shenyang Pharmaceutical University Shenyang 110016 P. R. China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HZHongyuan Zhang
Hongyuan Zhang
ZZZhiqiang Zhao
Zhiqiang Zhao
SSShengnan Sun
Shengnan Sun
SZSen Zhang
Sen Zhang
YWYuequan Wang
Yuequan Wang
Cong LuoCong Luo
Cong Luo
Thrombotic cerebro-cardiovascular diseases are the leading causes of disability and death worldwide. However, current drug therapeutics are compromised by narrow therapeutic windows, unsatisfactory thrombolysis effects, severe bleeding events, and high recurrence rates. In this study, we exploit a self-propelling nano-penetrator with high fuel loading and controllable motion features, which is molecularly co-assembled using a photothermal photosensitizer (DiR) and a photothermal-activable NO donor (BNN6). The precisely engineered nano-penetrator of the BNN6-DiR fuel pair shows distinct advantages in terms of NO productivity and autonomous motion under laser irradiation. In animal models of artery/vein thrombosis and acute ischemic stroke, the self‐fueled nano-penetrator enables self-navigated thrombus-homing accumulation, self-propelled clot deep penetration, fluorescence image-guided photothermal/mechanical thrombolysis, and NO-mediated prevention of thrombosis recurrence and acute ischemic stroke salvage. As expected, the molecularly self-fueled nano-penetrator displayed favorable therapeutic outcomes without bleeding risk compared to the clinically available thrombolytic drug. This study offers a facile, safe, and effective nonpharmaceutical modality towards the clinical treatment of thrombosis and ischemic stroke.

23 May 2024 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
DSDongqi Sun
Dongqi Sun
XSXinxin Sun
Xinxin Sun
XZXuan Zhang
Xuan Zhang
JWJiaping Wu
Jiaping Wu
XSXianbao Shi
Xianbao Shi
SZShenwu Zhang
Shenwu Zhang

20 September 2022 in Journal of Controlled Release
Verified
Journal Article
Closed access
QWQiu Wang
Qiu Wang
ZWZhe Wang
Zhe Wang
XSXinxin Sun
Xinxin Sun
QJQikun Jiang
Qikun Jiang
BSBingjun Sun
Bingjun Sun
JSJin Sun
Jin Sun

31 August 2023 in Journal of Controlled Release
Verified
Journal Article
Closed access
ZZZhiqiang Zhao
Zhiqiang Zhao
XSXinzhu Shan
Xinzhu Shan
HZHongyuan Zhang
Hongyuan Zhang
XSXianbao Shi
Xianbao Shi
PHPeiqi Huang
Peiqi Huang
SZShenwu Zhang
Shenwu Zhang

3 March 2022 in Asian Journal of Pharmaceutical Sciences
Verified
Journal Article
Open access
CWChen Wang
Chen Wang
HYHan Yu
Han Yu
XYXiaohong Yang
Xiaohong Yang
XZXuanbo Zhang
Xuanbo Zhang
YWYuequan Wang
Yuequan Wang
Cong LuoCong Luo
Cong Luo
Pure drug-assembled nanosystem provides a facile and promising solution for simple manufacturing of nanodrugs, whereas a lack of understanding of the underlying assembly mechanism and the inefficient and uncontrollable drug release still limits the development and application of this technology. Here, a simple and practical nanoassembly of DOX and DiR is constructed on basis of their co-assembly characteristics. Multiple interaction forces are found to drive the co-assembly process. Moreover, DOX release from the nanoassembly can be well controlled by the acidic tumor microenvironment and laser irradiation, resulting in favorable delivery efficiency of DiR and DOX in vitro and in vivo. As expected, the nanoassembly with high therapeutic safety completely eradicated the mice triple negative breast cancer cells (4T1) on BALB/c mice, owing to synergistic chemo-photothermal therapy. More interestingly, DiR and DOX synergistically induce immunogenic cell death (ICD) of tumor cells after treatment, enabling the mice to acquire immune memory against tumor growth and recurrence. Such a facile nanoassembly technique provides a novel multimodal cancer treatment platform of chemotherapy/phototherapy/immunotherapy.

10 February 2024 in Chemical Engineering Journal
Verified
Journal Article
Closed access
XYXiaohong Yang
Xiaohong Yang
XSXinxin Sun
Xinxin Sun
JLJin Lei
Jin Lei
XSXianbao Shi
Xianbao Shi
SZShenwu Zhang
Shenwu Zhang
Cong LuoCong Luo
Cong Luo